Moreover, no direct correlation was noted for the number of HER2+EVs detected by flow cytometry in the plasma of breast cancer patients with the size of the tumour, the tumour grading, or the presence of metastasis (Suppl. This evidence concerns the gene ERBB2 and neoplasm.